Washington Times asks physicians about the growing talk of GLP-1 drugs as an anti-aging fix, and they urge caution before reading too much into it.
Recap by typeshit. Full story at Washington Times.
A brief Facebook post says a daily pill might help people who worry about putting weight back on once they come off Wegovy. It names no drug or study.
In 367 adults with type 2 diabetes, the top combo dose beat 14.8% on tirzepatide alone at 48 weeks. Lilly plans phase 3 by late 2026.
Alessandro Sette's lab will track T cell responses in people before and after starting GLP-1s, including to Parkinson's-linked proteins. He is enrolling himself too.
12:35
Dr. Eric Berg walks through the basics of peptides in a broad explainer. Treat any health claims as his own views.
He points to a November 2026 study he says suggests semaglutide and other GLP-1 drugs may help beyond diabetes and obesity in people with schizophrenia.
Healio
ACOG says up to 1 in 300 women are exposed before pregnancy. It advises discussing contraception and, for those who breastfeed, shorter acting drugs and watching infant weight.
Loading…